It is therefore necessary to investigate how agmatine is affected in schizophrenia at the subcellular levels, and how its biosynthesis (arginine decarboxylase) and degradation (agmatinase) enzymes change in the brains of schizophrenic individuals in the future. Here, AZIN2 is linked to schizophrenia.